SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

140.8744507

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

17001.29

EPS(TTM)

Face Value()

Div & Yield %

0.47

Back

Advik Capital reports consolidated net profit of Rs 0.59 crore in the September 2025 quarter

Oct 16,2025

Net profit of Advik Capital reported to Rs 0.59 crore in the quarter ended September 2025 as against net loss of Rs 0.19 crore during the previous quarter ended September 2024. Sales declined 94.46% to Rs 5.67 crore in the quarter ended September 2025 as against Rs 102.37 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	5.67	102.37	-94
OPM %	73.19	2.35	-
PBDT	0.60	0.14	329
PBT	0.10	-0.02	LP
NP	0.59	-0.19	LP

85,041.45 -367.25 ( -0.43%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)